Jerry S. Powell, M.D. 
Clinical/Research Interests
Title:
Specialty:
Center/Program Affiliation:
Address:
4501 X St., Suite 3016
Sacramento, CA 95817
Phone:
Education:
Seattle, Washington
M.D. 1976
Stanford University
Palo Alto, California
A.B. 1972
Internships:
Chicago, Illinois
1976-1979
Residency:
Seattle, Washington
1979-1980
Internal Medicine
University of Chicago Hospitals and Clinics
Chicago, Illinois
1976-1979
Internal Medicine
Fellowships:
Seattle, Washington
1980-1982
Hematology/Oncology
Board Certifications:
American Board of Internal Medicine, Medical Oncology, 1981
American Board of Internal Medicine, 1979
Professional Memberships:
American Heart Association
American Society of Hematology
Hemophilia and Thrombosis Research Society
International Society on Thrombosis and Hemostasis
Western Society for Clinical Investigation
Honors and Awards:
Individual National Research Service Award, National Institutes of Health, 1981
Associate Investigator Award, Veterans Administration, 1981
Teaching Excellence Award, Resident, University of Chicago, 1977
Medical Student Research Stipend Award for Research in Nucleic Acid Biochemistry, University of Washington, 1973
Select Recent Publications:
Kessler CM, Friedman K, Schwartz BA, Gill JC, Powell JS; Wilate PK Study Investigators. The pharmacokinetic diversity of two von Willebrand factor (VWF)/ factor VIII (FVIII) concentrates in subjects with congenital von Willebrand disease. Results from a prospective, randomised crossover study. Thromb Haemost. 2011 Aug;106(2):279-88. Epub 2011 Jul 4.
Kulkarni R, Soucie JM, Lusher J, Presley R, Shapiro A, Gill J, Manco-Johnson M, Koerper M, Mathew P, Absire T, Dimichele D, Hoots K, Janco R, Nugent 0, Geraghty S, Evatt B; the Haemophilia Treatment Center Network Investigators [Powell JS, member local PI in CDC network]. Sites of initial bleeding episodes, mode of delivery and age of diagnosis in babies with haemophilia diagnosed before the age of 2 years: a report from The Centers for Disease Control and Prevention's (CDC) Universal Data Collection (UDC) project. Haemophilia, [Epub ahead of print].
Metjian AD, Wang C, Sood SL, Cuker A, Peterson SM, Soucie JM, Konkle BA; HTCN Study Investigators [Powell JS, member, local PI in CDC network]. Bleeding symptoms and laboratory correlation in patients with severe von Willebrand disease. Haemophilia, 15(4):918-925.
Powell JS. Recombinant factor VIII in the management of hemophilia A: current use and future promise. Ther Clin Risk Manag, 5(2):391-402.
Walsh CE, Valentino LA. [Powell JS, UCD investigator] Factor VIII prophylaxis for adult patients with severe haemophilia A: results of a US survey of attitudes and practices. Haemophilia. 2009 Sep;15(5):1014-21. Epub 2009 Jun 1.
Ashrani AA, Key NS, Soucie JM, Duffy N, Forsyth A, Geraghty S, Universal Data Collection Project Investigators [Powell JS, member, local PI in CDC network]. Septic arthritis in males with haemophilia. Haemophilia, 14(3):494-503.
Powell J. The next generation of anti-haemophilia factor, factor VIII. Long-lasting protection from spontaneous bleeding, are we there yet? Thromb Haemost, 100(3):365-6.
Walsh CE; Adult Prophylaxis Study Group [Powell JS, UCD investigator]. Prophylaxis for adults with severe haemophilia: a compelling need for evidence-based guidelines. Haemophilia. 2008 Mar;14(2):385-6. Epub 2008 Jan 14.
Powell JS, Nugent OJ, Harrison, JA, Soni A, Luk A, Stass H, Gorina E. Safety and~ pharmacokinetics of a recombinant factor VIII with pegylated liposomes in severe hemophilia A. J Thromb Haemost, 6(2):277-83.
Powell JS. Liposomal approach towards the development of a longer-acting factor VIII. Haemophilia; 13 Suppl 2:23-8.
